These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 30245959)

  • 21. Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase.
    Shimizu M; Fukami T; Nakajima M; Yokoi T
    Drug Metab Dispos; 2014 Jul; 42(7):1103-9. PubMed ID: 24751575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine Carboxylesterases: Evidence for Two CES1 and Five Families of CES Genes on Chromosome 18.
    Holmes RS; Cox LA; Vandeberg JL
    Comp Biochem Physiol Part D Genomics Proteomics; 2009 Mar; 4(1):11-20. PubMed ID: 20161341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
    Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
    Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic identification and characterization of carboxylesterases in cynomolgus macaques.
    Uno Y; Uehara S; Hosokawa M; Imai T
    Drug Metab Dispos; 2014 Dec; 42(12):2002-6. PubMed ID: 25256558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hydrolysis by carboxylesterase and disposition of prodrug with ester moiety].
    Imai T
    Yakugaku Zasshi; 2007 Apr; 127(4):611-9. PubMed ID: 17409690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new class of mammalian carboxylesterase CES6.
    Holmes RS; Cox LA; Vandeberg JL
    Comp Biochem Physiol Part D Genomics Proteomics; 2009 Sep; 4(3):209-17. PubMed ID: 20161041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biotransformation Capacity of Carboxylesterase in Skin and Keratinocytes for the Penta-Ethyl Ester Prodrug of DTPA.
    Fu J; Sadgrove M; Marson L; Jay M
    Drug Metab Dispos; 2016 Aug; 44(8):1313-8. PubMed ID: 27130352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct patterns of aging effects on the expression and activity of carboxylesterases in rat liver and intestine.
    Ohura K; Tasaka K; Hashimoto M; Imai T
    Drug Metab Dispos; 2014 Feb; 42(2):264-73. PubMed ID: 24271336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baboon carboxylesterases 1 and 2: sequences, structures and phylogenetic relationships with human and other primate carboxylesterases.
    Holmes RS; Glenn JP; VandeBerg JL; Cox LA
    J Med Primatol; 2009 Feb; 38(1):27-38. PubMed ID: 19187434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic structure and transcriptional regulation of the rat, mouse, and human carboxylesterase genes.
    Hosokawa M; Furihata T; Yaginuma Y; Yamamoto N; Koyano N; Fujii A; Nagahara Y; Satoh T; Chiba K
    Drug Metab Rev; 2007; 39(1):1-15. PubMed ID: 17364878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboxylesterase inhibitors from clinically available medicines and their impact on drug metabolism.
    Song YQ; Jin Q; Wang DD; Hou J; Zou LW; Ge GB
    Chem Biol Interact; 2021 Aug; 345():109566. PubMed ID: 34174250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
    Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
    Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human carboxylesterases: an update on CES1, CES2 and CES3.
    Sanghani SP; Sanghani PC; Schiel MA; Bosron WF
    Protein Pept Lett; 2009; 16(10):1207-14. PubMed ID: 19508181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic carboxylesterases are differentially regulated in PPARĪ±-null mice treated with perfluorooctanoic acid.
    Wen X; Baker AA; Klaassen CD; Corton JC; Richardson JR; Aleksunes LM
    Toxicology; 2019 Mar; 416():15-22. PubMed ID: 30685356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine reduces CES1, CES2, and CYP3A4 expression through decreasing PXR and increasing DEC1 in HepG2 cells.
    Shang W; Liu J; Chen R; Ning R; Xiong J; Liu W; Mao Z; Hu G; Yang J
    Xenobiotica; 2016; 46(5):393-405. PubMed ID: 26340669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of Human Liver and Intestinal Carboxylesterases to the Hydrolysis of Selexipag InĀ Vitro.
    Imai S; Ichikawa T; Sugiyama C; Nonaka K; Yamada T
    J Pharm Sci; 2019 Feb; 108(2):1027-1034. PubMed ID: 30267780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the inhibitory effects of pyrethroids against human carboxylesterases.
    Lei W; Wang DD; Dou TY; Hou J; Feng L; Yin H; Luo Q; Sun J; Ge GB; Yang L
    Toxicol Appl Pharmacol; 2017 Apr; 321():48-56. PubMed ID: 28242322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of natural pentacyclic triterpenoids as potent and selective inhibitors against human carboxylesterase 1.
    Song PF; Zhu YD; Ma HY; Wang YN; Wang DD; Zou LW; Ge GB; Yang L
    Fitoterapia; 2019 Sep; 137():104199. PubMed ID: 31175950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone-induced methylprednisolone hemisuccinate hydrolase: its identification as a member of the rat carboxylesterase 2 family and its unique existence in plasma.
    Furihata T; Hosokawa M; Fujii A; Derbel M; Satoh T; Chiba K
    Biochem Pharmacol; 2005 Apr; 69(8):1287-97. PubMed ID: 15794950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The inhibition of carboxylesterases by praeruptorin C, D and E].
    Du Z; Chen DW; Fu ZW; Fang ZZ; Yang K
    Yao Xue Xue Bao; 2017 Jan; 52(1):66-70. PubMed ID: 29911771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.